Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes

Abstract Arathi Srinivasan Aims The aim was to study cytogenetics and molecular genetic profile in pediatric B-acute lymphoblastic leukemia (ALL) and correlate it with induction outcomes....

Full description

Bibliographic Details
Main Authors: Ajeitha Loganathan, Rishab Bharadwaj, Arathi Srinivasan, Julius Xavier Scott
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-10-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754337
_version_ 1828040644786913280
author Ajeitha Loganathan
Rishab Bharadwaj
Arathi Srinivasan
Julius Xavier Scott
author_facet Ajeitha Loganathan
Rishab Bharadwaj
Arathi Srinivasan
Julius Xavier Scott
author_sort Ajeitha Loganathan
collection DOAJ
description Abstract Arathi Srinivasan Aims The aim was to study cytogenetics and molecular genetic profile in pediatric B-acute lymphoblastic leukemia (ALL) and correlate it with induction outcomes. Subjects and Methods A retrospective study of cytogenetics and molecular genetics of 98 children with B-cell ALL from January 2013 to May 2018 was done. Cytogenetics and molecular genetics were done in the bone marrow using multiplex reverse transcription polymerase chain reaction and G-banded karyotyping, respectively. Minimal residual disease (MRD) assessment was done at the end of induction by flowcytometry. Results Of the 98 children, 83 (84.6%) had evaluable cytogenetics, with 11 (13.25%) being abnormal karyotypes. Of the 11 abnormal karyotypes, seven children (8.4%) had hyperdiploidy, one had hypodiploidy, and three had miscellaneous findings. In molecular genetics, TEL–AML1 (ETV6/RUNX1)[t(12;21)] was the most common fusion gene abnormality (12.2% [12/98]), followed by E2A–PBX1 [t(1;19)] (5%), BCR/ABL1 [t(9;22)] (3%), and MLL–AF4 [t(4;11)] (1%). All the 98 children attained morphologic remission at the end of induction. All children with hyperdiploidy (7/7) attained remission and MRD negativity, but one expired during maintenance chemotherapy of disseminated tuberculosis. The child with hypodiploidy was MRD-positive. Three (25%) children with t (12;21) were MRD-positive. All children with Ph + ALL, t(1:19), and t(4;11) were MRD-negative. Fifty-two children had no detected abnormalities, six of whom had MRD positivity (11.5%). Conclusion Cytogenetic and molecular genetic subgrouping prognosticates ALL outcomes. Although 25% of TEL–AML + children had MRD positivity, larger studies are required to validate the same. End-of-induction MRD outcomes did not correlate with chromosomal aberrations.
first_indexed 2024-04-10T16:59:21Z
format Article
id doaj.art-2eff8ed3c7e843c785d0b6899aef77e6
institution Directory Open Access Journal
issn 2278-330X
2278-4306
language English
last_indexed 2024-04-10T16:59:21Z
publishDate 2022-10-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series South Asian Journal of Cancer
spelling doaj.art-2eff8ed3c7e843c785d0b6899aef77e62023-02-07T00:41:52ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-43062022-10-01110435336010.1055/s-0042-1754337Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction OutcomesAjeitha Loganathan0Rishab Bharadwaj1Arathi Srinivasan2Julius Xavier Scott3Department of Pediatric Hematology and Oncology, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, IndiaDepartment of Pediatric Hematology and Oncology, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, IndiaDepartment of Pediatric Oncology, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, IndiaDepartment of Pediatric Oncology, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, IndiaAbstract Arathi Srinivasan Aims The aim was to study cytogenetics and molecular genetic profile in pediatric B-acute lymphoblastic leukemia (ALL) and correlate it with induction outcomes. Subjects and Methods A retrospective study of cytogenetics and molecular genetics of 98 children with B-cell ALL from January 2013 to May 2018 was done. Cytogenetics and molecular genetics were done in the bone marrow using multiplex reverse transcription polymerase chain reaction and G-banded karyotyping, respectively. Minimal residual disease (MRD) assessment was done at the end of induction by flowcytometry. Results Of the 98 children, 83 (84.6%) had evaluable cytogenetics, with 11 (13.25%) being abnormal karyotypes. Of the 11 abnormal karyotypes, seven children (8.4%) had hyperdiploidy, one had hypodiploidy, and three had miscellaneous findings. In molecular genetics, TEL–AML1 (ETV6/RUNX1)[t(12;21)] was the most common fusion gene abnormality (12.2% [12/98]), followed by E2A–PBX1 [t(1;19)] (5%), BCR/ABL1 [t(9;22)] (3%), and MLL–AF4 [t(4;11)] (1%). All the 98 children attained morphologic remission at the end of induction. All children with hyperdiploidy (7/7) attained remission and MRD negativity, but one expired during maintenance chemotherapy of disseminated tuberculosis. The child with hypodiploidy was MRD-positive. Three (25%) children with t (12;21) were MRD-positive. All children with Ph + ALL, t(1:19), and t(4;11) were MRD-negative. Fifty-two children had no detected abnormalities, six of whom had MRD positivity (11.5%). Conclusion Cytogenetic and molecular genetic subgrouping prognosticates ALL outcomes. Although 25% of TEL–AML + children had MRD positivity, larger studies are required to validate the same. End-of-induction MRD outcomes did not correlate with chromosomal aberrations.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754337acute lymphoblastic leukemiacytogeneticsinductionminimal residual diseasepediatric
spellingShingle Ajeitha Loganathan
Rishab Bharadwaj
Arathi Srinivasan
Julius Xavier Scott
Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
South Asian Journal of Cancer
acute lymphoblastic leukemia
cytogenetics
induction
minimal residual disease
pediatric
title Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
title_full Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
title_fullStr Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
title_full_unstemmed Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
title_short Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
title_sort cytogenetics and molecular genetics in pediatric acute lymphoblastic leukemia all and its correlation with induction outcomes
topic acute lymphoblastic leukemia
cytogenetics
induction
minimal residual disease
pediatric
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754337
work_keys_str_mv AT ajeithaloganathan cytogeneticsandmoleculargeneticsinpediatricacutelymphoblasticleukemiaallanditscorrelationwithinductionoutcomes
AT rishabbharadwaj cytogeneticsandmoleculargeneticsinpediatricacutelymphoblasticleukemiaallanditscorrelationwithinductionoutcomes
AT arathisrinivasan cytogeneticsandmoleculargeneticsinpediatricacutelymphoblasticleukemiaallanditscorrelationwithinductionoutcomes
AT juliusxavierscott cytogeneticsandmoleculargeneticsinpediatricacutelymphoblasticleukemiaallanditscorrelationwithinductionoutcomes